Gordon R. B. Skinner
Corporate Officer/Principal bij Vaccine Research International Plc
Actieve functies van Gordon R. B. Skinner
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Vaccine Research International Plc
 Vaccine Research International Plc Miscellaneous Commercial ServicesCommercial Services Vaccine Research International Plc is a British company that focuses on conducting clinical trials to evaluate the effectiveness of vaccine SA75 in preventing staphylococcal infections in hospital patients and the wider community. | Corporate Officer/Principal | 09-04-2010 | - |
Loopbaan van Gordon R. B. Skinner
Eerdere bekende functies van Gordon R. B. Skinner
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
HIV-VAC, Inc.
 HIV-VAC, Inc. Miscellaneous Commercial ServicesCommercial Services HIV-VAC, Inc. develops and markets proposed vaccine designed to combat HIV/AIDS. This proposed vaccine, which is called NFU.Ac.HIV, was developed by Dr. Gordon Skinner, director of research, through the University of Birmingham, in the U.K. The proposed vaccine was licensed to Intracell Vaccines Limited from the University of Birmingham. The company was founded in 1997 and is headquartered in Ontario, CA. | Directeur/Bestuurslid | 09-04-2010 | 28-10-2010 |
| Hoofd Techniek/Wetenschap/O&O | 09-04-2010 | 28-10-2010 | |
| GRUPO INTERNATIONAL INC. | Directeur/Bestuurslid | 01-04-1999 | - |
| Hoofd Techniek/Wetenschap/O&O | 01-04-1999 | - | |
Intracell Vaccines Ltd.
 Intracell Vaccines Ltd. Medical SpecialtiesHealth Technology Intracell Vaccines Ltd. develops vaccines. The company is headquartered in Gaithersburg, MD. | Directeur/Bestuurslid | 09-04-2010 | - |
Opleiding van Gordon R. B. Skinner
| University of Glasgow | Undergraduate Degree |
| University of Birmingham | Doctorate Degree |
Statistieken
Internationaal
| Verenigd Koninkrijk | 4 |
| Canada | 3 |
| Verenigde Staten | 2 |
Operationeel
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 2 |
Sectoraal
| Commercial Services | 3 |
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GRUPO INTERNATIONAL INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
HIV-VAC, Inc.
HIV-VAC, Inc. Miscellaneous Commercial ServicesCommercial Services HIV-VAC, Inc. develops and markets proposed vaccine designed to combat HIV/AIDS. This proposed vaccine, which is called NFU.Ac.HIV, was developed by Dr. Gordon Skinner, director of research, through the University of Birmingham, in the U.K. The proposed vaccine was licensed to Intracell Vaccines Limited from the University of Birmingham. The company was founded in 1997 and is headquartered in Ontario, CA. | Commercial Services |
Intracell Vaccines Ltd.
Intracell Vaccines Ltd. Medical SpecialtiesHealth Technology Intracell Vaccines Ltd. develops vaccines. The company is headquartered in Gaithersburg, MD. | Health Technology |
Vaccine Research International Plc
Vaccine Research International Plc Miscellaneous Commercial ServicesCommercial Services Vaccine Research International Plc is a British company that focuses on conducting clinical trials to evaluate the effectiveness of vaccine SA75 in preventing staphylococcal infections in hospital patients and the wider community. | Commercial Services |
